Showing results (11-20 of 203) with videos related to
Sort By:
Pageof 21
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trialsMarc BuyseStatistics in Medicine|December 21, 2010
Generalized pairwise comparisons of prioritized outcomes in the two-sample problemMarc BuyseInternational Journal of Clinical Oncology|April 25, 2009
Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancerMarc BuyseAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Limitations of adaptive clinical trialsMarc BuyseTherapie|February 5, 2017
How to measure the net benefit of treatment?François Gueyffier, Pascal Piedbois, Jean-François Bergmann, et al.Current Opinion in Oncology|March 12, 2013
Omics-based clinical trial designsMarc Buyse, Stefan MichielsPharmaceutical Statistics|November 4, 2006
Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validationTomasz Burzykowski, Marc BuyseJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trialThierry Andre, Philippe Colin, Christophe Louvet, et al.Current Opinion in Oncology|June 17, 2020
Statistical aspects in adjuvant and neoadjuvant trials for gastrointestinal cancer in 2020: focus on time-to-event endpointsEverardo D Saad, Marc BuyseActa Oncologica (Stockholm, Sweden)|September 15, 2012
Non-inferiority trials in breast and non-small cell lung cancer: choice of non-inferiority margins and other statistical aspectsEverardo D Saad, Marc BuysePageof 21